TY - JOUR
T1 - Carotid intima media thickness is associated with plasma adiponectin but not with the leptin:adiponectin ratio independently of metabolic syndrome
AU - Dullaart, Robin P. F.
AU - Kappelle, Paul J. W. H.
AU - Dallinga-Thie, Geesje M.
PY - 2010
Y1 - 2010
N2 - A recent report showed no benefit of the leptin:adiponectin ratio (L:A ratio) over individual adipokine levels in CHD prediction [8]. We determined associations of carotid intima media thickness (IMT) with the L:A ratio taking account of cardiovascular risk factors in a high risk population. IMT, plasma leptin, adiponectin and the L:A ratio were determined in 161 middle-aged men and women (45% metabolic syndrome). IMT was associated inversely with adiponectin and positively with the L:A ratio in age- and sex-adjusted multiple linear regression analyses (P <0.001 for both). After controlling for metabolic syndrome, the independent association with adiponectin remained (P <0.001), but the relationship with the L:A ratio disappeared (P=0.126). Results were similar after additional adjustment for diabetes status or for insulin resistance. This study does not support the preferential use of the leptin:adiponectin ratio as a marker of atherosclerosis susceptibility
AB - A recent report showed no benefit of the leptin:adiponectin ratio (L:A ratio) over individual adipokine levels in CHD prediction [8]. We determined associations of carotid intima media thickness (IMT) with the L:A ratio taking account of cardiovascular risk factors in a high risk population. IMT, plasma leptin, adiponectin and the L:A ratio were determined in 161 middle-aged men and women (45% metabolic syndrome). IMT was associated inversely with adiponectin and positively with the L:A ratio in age- and sex-adjusted multiple linear regression analyses (P <0.001 for both). After controlling for metabolic syndrome, the independent association with adiponectin remained (P <0.001), but the relationship with the L:A ratio disappeared (P=0.126). Results were similar after additional adjustment for diabetes status or for insulin resistance. This study does not support the preferential use of the leptin:adiponectin ratio as a marker of atherosclerosis susceptibility
U2 - https://doi.org/10.1016/j.atherosclerosis.2010.03.024
DO - https://doi.org/10.1016/j.atherosclerosis.2010.03.024
M3 - Comment/Letter to the editor
C2 - 20398901
SN - 0021-9150
VL - 211
SP - 393
EP - 396
JO - Atherosclerosis
JF - Atherosclerosis
IS - 2
ER -